Monica Morrow

4.5k total citations · 1 hit paper
75 papers, 3.2k citations indexed

About

Monica Morrow is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Monica Morrow has authored 75 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Cancer Research, 30 papers in Oncology and 27 papers in Pathology and Forensic Medicine. Recurrent topics in Monica Morrow's work include Breast Cancer Treatment Studies (43 papers), Breast Lesions and Carcinomas (24 papers) and Breast Implant and Reconstruction (12 papers). Monica Morrow is often cited by papers focused on Breast Cancer Treatment Studies (43 papers), Breast Lesions and Carcinomas (24 papers) and Breast Implant and Reconstruction (12 papers). Monica Morrow collaborates with scholars based in United States, United Kingdom and Germany. Monica Morrow's co-authors include Andrew J. Dannenberg, Xi Kathy Zhou, Clifford A. Hudis, Luz A. Venta, Dilip D. Giri, Susan M. Gapstur, V. Craig Jordan, Patrick G. Morris, Kotha Subbaramaiah and Domenick J. Falcone and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Monica Morrow

68 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE Trial

2001 505 citations Larry Norton, Monica Morrow et al. profile →

Peers

Countries citing papers authored by Monica Morrow

Since Specialization

Citations

This map shows the geographic impact of Monica Morrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Morrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Morrow more than expected).

Fields of papers citing papers by Monica Morrow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Morrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Morrow. The network helps show where Monica Morrow may publish in the future.

Co-authorship network of co-authors of Monica Morrow

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Morrow. A scholar is included among the top collaborators of Monica Morrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Morrow. Monica Morrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predictors of response to neoadjuvant chemo-immunotherapy in metaplastic triple-negative breast cancer 2025 ·npj Breast Cancer ·Nour Abuhadra, Fresia Pareja, (unknown), (unknown), Hannah Y. Wen, Esra Dikoglu, (unknown), Stephanie Downs‐Canner, Larry Norton, George Plitas, (unknown), Sarat Chandarlapaty, Pedram Razavi, Mark E. Robson, Monica Morrow, Giacomo Montagna	0
2	Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer 2025 ·Annals of Surgical Oncology ·(unknown), Varadan Sevilimedu, (unknown), Nour Abuhadra, Monica Morrow, George Plitas, Stephanie Downs‐Canner	2
3	The Presence of Extensive Lymphovascular Invasion is Associated With Higher Risks of Local-Regional Recurrence Compared With Usual Lymphovascular Invasion in Curatively Treated Breast Cancer Patients 2024 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), Edi Brogi, Zhigang Zhang, Lior Z. Braunstein, Monica Morrow, Tracy‐Ann Moo, Mahmoud El‐Tamer, (unknown), Simon N. Powell, Atif J. Khan	2
4	De-escalation of breast and axillary surgery in exceptional responders to neoadjuvant systemic treatment 2021 ·The Lancet Oncology ·Joerg Heil, André Pfob, Monica Morrow	12
5	Evaluation of Local and Distant Recurrence Patterns in Patients with Triple-Negative Breast Cancer According to Age 2016 ·Annals of Surgical Oncology ·Julia Caroline Radosa, Anne Eaton, Michelle Stempel, (unknown), Cornelia Liedtke, Erich‐Franz Solomayer, Maria Margarete Karsten, Melissa Pilewskie, Monica Morrow, Tari A. King	37
6	Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer 2015 ·Clinical Cancer Research ·Neil M. Iyengar, Xi Kathy Zhou, Ayca Gucalp, Patrick G. Morris, Louise R. Howe, Dilip D. Giri, Monica Morrow, Hanhan Wang, Michaël Pollak, Lee W. Jones, Clifford A. Hudis, Andrew J. Dannenberg	162
7	Impact of Margin Assessment Method on Positive Margin Rate and Total Volume Excised 2013 ·Annals of Surgical Oncology ·Tracy‐Ann Moo, Lydia Choi, (unknown), Cristina Olcese, Alexandra S. Heerdt, Lisa M. Sclafani, Tari A. King, Anne S. Reiner, Sujata Patil, Edi Brogi, Monica Morrow, Kimberly J. Van Zee	26
8	COX-2 and PPARγ expression are potential markers of recurrence risk in mammary duct carcinoma in-situ 2008 ·BMC Cancer ·Swati Kulkarni, (unknown), Leslie K. Diaz, Elizabeth L. Wiley, Monica Morrow, Seema A. Khan	24
9	Effect of Time Interval on Residual Disease in Breast Cancer 2003 ·The American Journal of Surgical Pathology ·Elizabeth L. Wiley, Leslie K. Diaz, Sunil Badve, Monica Morrow	22
10	Selective Estrogen Receptor Modulation and Reduction in Risk of Breast Cancer, Osteoporosis, and Coronary Heart Disease 2001 ·JNCI Journal of the National Cancer Institute ·V. Craig Jordan, Susan M. Gapstur, Monica Morrow	137
11	Clinical highlights from the National Cancer Data Base, 2000 2000 ·CA A Cancer Journal for Clinicians ·A. Keith Stewart, Kirby I. Bland, L.S. McGinnis, Monica Morrow, Harmon J. Eyre	106
12	Management of the axillary nodes 1999 ·Breast Cancer ·Monica Morrow	38
13	Impact of Same-Day Screening Mammography Availability 1999 ·Archives of Internal Medicine ·Nancy C. Dolan, Mary McGrae McDermott, Monica Morrow, Luz A. Venta, Gary J. Martin	20
14	Axillary dissection: When and how radical? 1996 ·Seminars in Surgical Oncology ·Monica Morrow	23
15	Effect of reexcision on the success of breast-conserving surgery 1995 ·Annals of Surgical Oncology ·Thomas Kearney, Monica Morrow	44
16	The woman at increased risk for breast cancer: evaluation and management strategies 1995 ·CA A Cancer Journal for Clinicians ·Malcolm M. Bilimoria, Monica Morrow	79
17	Preoperative Evaluation of Abnormal Mammographic Findings to Avoid Unnecessary Breast Biopsies 1994 ·Archives of Surgery ·Monica Morrow	36
18	Molecular Mechanisms of Resistance to Tamoxifen Therapy in Breast Cancer 1993 ·PubMed ·Monica Morrow	28
19	Pre-cancerous breast lesions: Implications for breast cancer prevention trials 1992 ·International Journal of Radiation OncologyBiologyPhysics ·Monica Morrow	24
20	Chloroquine as a hyperthermia potentiator 1989 ·Journal of Surgical Research ·Monica Morrow, Christopher Hager, David S. Berger, Bozidar Djordjevic	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact